ICC.V - ICC Labs Inc.

TSXV - TSXV Delayed Price. Currency in CAD
1.42
-0.07 (-4.70%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.49
Open1.46
Bid1.42 x 0
Ask1.45 x 0
Day's Range1.42 - 1.48
52 Week Range0.84 - 2.00
Volume188,093
Avg. Volume347,211
Market Cap196.025M
Beta4.71
PE Ratio (TTM)83.53
EPS (TTM)0.02
Earnings DateApr 30, 2018 - May 4, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.43
  • GlobeNewswire20 days ago

    ICC Labs Receives Additional Land From the Government of Uruguay to Increase Its Production Capacity at Its Psychoactive Facility

    ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that the Government of Uruguay through its regulatory authority IRCCA (Cannabis Regulation and Control Institute) has granted the Company an additional land package of approximately 55,000 square foot in order to increase its production capacity. “A relevant milestone that demonstrates the confidence that the Government has placed in our Company to continue executing the terms of our recreational cannabis license granted for 5 years on January 14, 2016,” commented Alejandro Antalich, Chief Executive Officer of ICC Labs.

  • GlobeNewswire24 days ago

    Grit Capital launches GritCAMP Immersive Investment Conference in Muskoka July 25-27th 2018

    Grit Updates the Market on Recent Corporate Initiatives & Milestones. TORONTO, June 22, 2018-- GRIT CAPITAL INC. a capital markets advisory firm known for its aggressive“ out of the box” thinking to capture ...

  • GlobeNewswire25 days ago

    ICC Labs Completes Its First Outdoor Harvest and Prepares to Produce Its First CBD Extracts

    ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that it has completed its first outdoor harvest of hemp. The Company harvested hemp planted on approximately 430 acres of land distributed between its Canelones and Flores sites. The Company is now commencing the drying process for the harvested material, which will take between three to four weeks, and is preparing the soil for the next seeding, expected to occur next September.

  • GlobeNewswirelast month

    ICC Labs Announces Its First Presale Agreement in the European Market With VenPharma

    ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that KSK Labs, a 100% subsidiary of Global Group Kalapa, of which ICC Labs recently acquired 25%, subject to TSX Venture Exchange approval, has closed a presale agreement with a Spain-based company, VenPharma, in order to distribute cannabidiol (“CBD”) products in Spanish pharmacies and drugstores. The agreed first order is of 140,000 CBD products between sublingual CBD oils of 2% and 10%, CBD creams and infusions based on hemp, to be distributed through 500 point of sales. The intention with the next orders is to sell over than 370,000 CBD products annually through all the 1,300 points of sales.

  • June Undervalued Stock Picks
    Simply Wall St.last month

    June Undervalued Stock Picks

    Undervalued companies, such as Big 8 Split and ICC Labs, trade at a price less than their true values. Smart investors can make money from this discrepancy by buying theseRead More...

  • GlobeNewswirelast month

    ICC Labs Announces Its First Presale Agreement of CBD/THC Extracts and CBD/THC Oils for Distribution in Colombia

    ICC Labs enters into its first CBD/THC presale agreement in Colombia. Colombia is the third country in the Latin American market where ICC Labs has now taken steps to commence sales, after México and Brazil, opening up large potential markets with a total population of approximately 380 million people. VANCOUVER, British Columbia, June 05, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce it has entered into a presale agreement with a Colombia based company, Hlessing Industries (“Hlessing”) to supply cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) derivatives for medicinal purposes in Colombia.

  • GlobeNewswire2 months ago

    ICC Labs Files Financial Results for the First Quarter Ended March 31, 2018

    ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce it has filed its interim financial results for the first quarter ended March 31, 2018. The financial statements and management discussion and analysis for the three months ended March 31, 2018, are available on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on ICC Labs' website at www.icclabs.com. During the first quarter of 2018, the Company continued to take steps to expand its footprint in the Latin American market, and to gain access to the European and Canadian markets.

  • GlobeNewswire2 months ago

    ICC Labs Signs LOI to Export Cannabis to Germany for Medicinal Purposes

    ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that it has signed a letter of intent with CanPharma GmbH (“CanPharma”), a licensed importer and wholesaler of narcotics in the Federal Republic of Germany. Through its relationship with CanPharma, ICC Labs intends to export to Germany cannabidiol (CBD) isolate, oils and other derivatives, as well as various medicinal tetrahydrocannabinol (THC) cannabis products, including dried flowers and cannabis extracts from our facilities in Uruguay and Colombia. The export arrangement for (THC) cannabis products is subject to receipt of the requisite regulatory approvals and the negotiation of definitive agreements by the end of second quarter in 2018.

  • GlobeNewswire2 months ago

    ICC Labs Receives Organic Hemp Certification, Readies for Harvest and Continues Construction of Laboratory  

    ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that its wholly-owned subsidiary, Tersum S.A., obtained a 100% organic certificate for hemp (Cannabis Sativa) from the Organización Internacional Agropecuaria. The certification applies to hemp produced at the Company’s Canelones site in Uruguay, where the Company is authorized by the Ministry of Agriculture to grow hemp on up to 101 acres.

  • GlobeNewswire2 months ago

    ICC Labs Files Results for the Year Ended December 31, 2017

    Closed Cdn. $23 million bought deal financing. Commenced sales of recreational cannabis in Uruguay. Completed construction of 21,528 sq. ft. greenhouse in Uruguay for the production of cannabidiol strains ...

  • GlobeNewswire3 months ago

    Construction Begins on Colombian Cannabis Cultivation Greenhouse

    ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that it has started building a 124,000 sq. ft. greenhouse in Tabio, Cundinamarca, close to Bogotá, where the Company intends to produce psychoactive cannabis plants with up to 20% THC content for medicinal purposes. The greenhouse will be located on a total of 172,223 sq. ft. of land leased by ICC Labs which will also provide the area required to grow, store and manufacture derivatives, allowing ICC Labs to fully trace product through its production cycle. Alejandro Antalich, Chief Executive Officer of ICC Labs, commented, “We are very enthusiastic about the construction of our Colombian greenhouse as it is a major milestone in the commencement of our Colombian operations.

  • GlobeNewswire3 months ago

    ICC Labs Enters Into Letter of Intent With Eurofarma Uruguay S.A., a Member of the Brazilian-Owned Multinational Eurofarma Group of Pharmaceutical Companies

    VANCOUVER, British Columbia, April 19, 2018-- ICC Labs Inc. is pleased to announce that one of its Uruguayan subsidiaries has entered into a letter of intent with Eurofarma Uruguay S.A., a member of the ...

  • CNW Group4 months ago

    IIROC Trading Resumption - ICC

    VANCOUVER , March 28, 2018 /CNW/ - Trading resumes in: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Resumption (ET): 1:30 PM IIROC can make a decision to impose a temporary suspension (halt) of trading ...

  • CNW Group4 months ago

    IIROC Trading Halt - ICC

    VANCOUVER , March 28, 2018 /CNW/ - The following issues have been halted by IIROC: Company: ICC LABS INC. TSX-Venture Symbol: ICC Reason: Pending Company Contact Halt Time (ET): 9:18 AM IIROC can make ...

  • Marketwired5 months ago

    ICC Labs Announces Application for Regulatory Approval for New 1 Million Square Foot Greenhouse for the Production and Export of THC Dry Flowers and Its Derivatives for Medicinal Purposes

    Highlights: Upon approval, the new 1 million square foot greenhouse will be located on government owned land in Uruguay. THC plants will be produced exclusively for medicinal...

  • Baystreet6 months ago

    Phivida’s Warrant Conversion Doubles Treasury in 24 Trading Days from IPO to $11 Million

    - Positions CDB Small Cap with Unrivaled Share Structure and Cash to Accelerate Global Agreements and ...

  • PR Newswire6 months ago

    IIROC Trading Resumption - ICC

    VANCOUVER , Jan. 25, 2018 /CNW/ - Trading resumes in: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Resumption (ET): 10:11:35.591 AM IIROC can make a decision to impose a temporary suspension (halt) of ...

  • PR Newswire6 months ago

    IIROC Trading Halt - ICC

    VANCOUVER , Jan. 25, 2018 /CNW/ - The following issues have been halted by IIROC: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Reason: Single Stock Circuit Breaker Halt Time (ET): 10:06:35.591 AM IIROC ...

  • Marketwired6 months ago

    ICC Labs Inc. Receives Medicinal Cannabis License in Colombia

    Highlights: The Ministry of Justice and Law of the Republic of Colombia granted ICC Labs Inc., through its subsidiary ICC International Cannabis Corp Colombia S.A.S., a license for the cultivation of non-psychoactive......